Schedule-dependent interaction between the proteosome inhibitor bortezomib and the EGFR-TK inhibitor erlotinib in human non-small cell lung cancer cell lines. (Q53531233)
Jump to navigation
Jump to search
scientific article published in August 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Schedule-dependent interaction between the proteosome inhibitor bortezomib and the EGFR-TK inhibitor erlotinib in human non-small cell lung cancer cell lines. |
scientific article published in August 2007 |
Statements
Schedule-dependent interaction between the proteosome inhibitor bortezomib and the EGFR-TK inhibitor erlotinib in human non-small cell lung cancer cell lines. (English)
Bilal Piperdi
Yi-He Ling
Roman Perez-Soler
1 August 2007
2
8
715-721